In Vitro Diagnostics Business Outlook, 2026 - Volume 5, Issue 1 and 2
Description
The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is undergoing constant change and growth.
In Vitro Diagnostics Business Outlook is a monthly intelligence publication designed to help industry professionals stay current in this fast-moving environment. Delivered in 12 issues annually, each issue focuses on a different segment of the IVD industry, providing timely insights, exclusive data, and in-depth analysis.
Featured Content
Each monthly issue provides:
2026 Editorial Focus
Topics vary month to month, reflecting evolving industry priorities. In 2026, subscribers can expect issues dedicated to:
Please Note: Single user allows for up to 3 users for this report.
In Vitro Diagnostics Business Outlook is a monthly intelligence publication designed to help industry professionals stay current in this fast-moving environment. Delivered in 12 issues annually, each issue focuses on a different segment of the IVD industry, providing timely insights, exclusive data, and in-depth analysis.
Featured Content
Each monthly issue provides:
- Market Data and Forecasts
- Comprehensive Market View
- M&A Activity Tracking
- Industry & Region Watch
- In-Depth News Analysis
2026 Editorial Focus
Topics vary month to month, reflecting evolving industry priorities. In 2026, subscribers can expect issues dedicated to:
- Reimbursement trends
- Quality control reagents
- Cardiac markers
- STI point-of-care testing
- Non-respiratory infectious diseases
- An overall IVD market trend analysis
- A forward-looking forecast of the respiratory testing market through 2027
- And more!
Please Note: Single user allows for up to 3 users for this report.
Table of Contents
30 Pages
- Overview of IVD Reimbursement
- Outlook: Reimbursement
- Briefings
- Agilent Full Year Fiscal 2025 Sales up 7% in Business YOY
- Mergers and Acquisitions
- Partnerships and Collaborations
- Industry Watch COVID-19/Flu Update
- Australia
- Announcements
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
